Literature DB >> 1564053

Childhood obsessive compulsive disorder.

J L Rapoport1, S E Swedo, H L Leonard.   

Abstract

Childhood obsessive compulsive disorder has recently been recognized as being more common than previously believed, supporting epidemiologic studies in adults that found rates far higher than clinical studies have suggested. Clinically, presentation is generally similar to that for adult patients, but compulsions may occur in the absence of obsessions although both obsessions and compulsions are common. Symptoms typically change over time, but almost all subjects at some time experienced excess washing as one of their symptoms. There is an increased rate of obsessive compulsive disorder and of motor tics in the relatives of children with obsessive compulsive disorder. As with Tourette's disorder, partial voluntary control of symptoms is usual. Prospective follow-up studies show continued disability from obsessive compulsive disorder and continued comorbidity with affective disorders. Obsessive compulsive symptoms are selectively associated with several childhood onset neurologic disorders such as Tourette's disorder and Sydenham's chorea, both presumed to be basal ganglia disorders. The implication of this association is that there may be hard-wired complex behaviors subsumed by basal ganglia frontal cortical pathways that are inappropriately released in obsessive compulsive disorder.

Entities:  

Mesh:

Year:  1992        PMID: 1564053

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  10 in total

1.  Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.

Authors:  C J McDougle; L E Kresch; D J Posey
Journal:  J Autism Dev Disord       Date:  2000-10

2.  Intrusive thoughts in a non-clinical adolescent population.

Authors:  M Allsopp; T Williams
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-04       Impact factor: 4.785

3.  Kinematic analysis of handwriting movements in patients with obsessive-compulsive disorder.

Authors:  P Mavrogiorgou; R Mergl; P Tigges; J El Husseini; A Schröter; G Juckel; M Zaudig; U Hegerl
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

4.  Association of Obsessive-Compulsive Disorder With Objective Indicators of Educational Attainment: A Nationwide Register-Based Sibling Control Study.

Authors:  Ana Pérez-Vigil; Lorena Fernández de la Cruz; Gustaf Brander; Kayoko Isomura; Andreas Jangmo; Inna Feldman; Eva Hesselmark; Eva Serlachius; Luisa Lázaro; Christian Rück; Ralf Kuja-Halkola; Brian M D'Onofrio; Henrik Larsson; David Mataix-Cols
Journal:  JAMA Psychiatry       Date:  2018-01-01       Impact factor: 21.596

Review 5.  A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Authors:  L L Carpenter; C J McDougle; C N Epperson; L H Price
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 6.  Obsessive-compulsive disorder in children and adolescents. A review of the literature.

Authors:  Per Hove Thomsen
Journal:  Eur Child Adolesc Psychiatry       Date:  1994-07       Impact factor: 4.785

7.  Psychosocial dysfunction and family burden in schizophrenia and obsessive compulsive disorder.

Authors:  Josy K Thomas; P N Suresh Kumar; A N Verma; V K Sinha; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2004-07       Impact factor: 1.759

Review 8.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

Review 9.  Anxiety disorders. Focus on obsessive-compulsive disorder.

Authors:  L Warneke
Journal:  Can Fam Physician       Date:  1993-07       Impact factor: 3.275

10.  Obsessive-compulsive traits in children and adolescents with Asperger syndrome.

Authors:  Liliana Ruta; Diego Mugno; Valentina Genitori D'Arrigo; Benedetto Vitiello; Luigi Mazzone
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-06-26       Impact factor: 4.785

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.